Local synthesis and dual actions of progesterone in the nervous system: Neuroprotection and myelination

Growth Hormone and IGF Research

Volumn 14, Issue SUPPL. A, 2004, Pages

  Schumacher, Michael ^a   Guennoun, Rachida ^a   Robert, Françoise ^a   Carelli, Claude ^a   Gago, Nathalie ^a   Ghoumari, Abdel ^a   Gonzalez Deniselle, Maria C ^b   Gonzalez, Susana L ^b   Ibanez, Chrystelle ^a   Labombarda, Florencia ^b   Coirini, Héctor ^b   Baulieu, Etienne Emile ^a   De Nicola, Alejandro F ^b  

^a INSERM   (France)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cerebellum; Motoneurons; Myelination; Neuroprotection; Neurosteroids; Progesterone; Schwann cells; Spinal cord; Spinal nerve

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); NEUROSTEROID; PREGNENOLONE; PROGESTERONE;

AGING; ASTROCYTE; AUTOCRINE EFFECT; BRAIN REGION; BRAIN SLICE; CELL INTERACTION; CELL VIABILITY; COCULTURE; COGNITION; DEGENERATIVE DISEASE; DEMYELINATION; DISEASE MODEL; ENZYME ACTIVITY; ENZYME REGULATION; EXPLANT; GENE EXPRESSION REGULATION; GLIA CELL; HORMONE ACTION; HORMONE SENSITIVITY; HUMAN; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MACROGLIA; MOTONEURON; MOUSE; MUSCLE STRENGTH; MYELIN SHEATH; MYELINATION; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE FIBER REGENERATION; NERVOUS SYSTEM; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PARACRINE SIGNALING; PERIPHERAL NERVE; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; RAT; REVIEW; SCHWANN CELL; SCIATIC NERVE; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD MOTONEURON; SPINAL GANGLION; SURVIVAL RATE;

EID: 2542520714     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.03.007     Document Type: Review

References (167)

1. F. Labrie, T. Luu, C. Labrie, J. Simard, DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology, Front. Neuroendocrinol. 22 (2001) 185-212.
2. A. Scheepens, E.S. Sirimanne, B.H. Breier, R.G. Clark, P.D. Gluckman, C.E. Williams, Growth hormone as a neuronal rescue factor during recovery from CNS injury, Neuroscience 104 (2001) 677-687.
3. A. Scheepens, E. Sirimanne, E. Beilharz, B.H. Breier, M.J. Waters, P.D. Gluckman, C.E. Williams, Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury, Mol. Brain Res. 68 (1999) 88-100.
4. G.P. Cardona-Gomez, P. Mendez, L.L. Doncarlos, I. Azcoitia, L.M. Garcia-Segura, Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection, Brain Res. Rev. 37 (2001) 320-334.
5. G.R. Bock, J.A. Goode, Non-reproductive actions of sex steroids, in: CIBA Foundation Symposium, vol. 191, Wiley, Chichester, 1995, pp. 1-307.
6. E.E. Baulieu, P. Robel, M. Schumacher, Neurosteroids. A New Regulatory Function in the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 1-378.
7. E.E. Baulieu, P. Robel, M. Schumacher, Neurosteroids: beginning of the story, Int. Rev. Neurobiol. 46 (2001) 1-32.
8. E.E. Baulieu, Neurosteroids: a new function in the brain, Biol. Cell 71 (1991) 3-10.
9. P.F. Hall, Role of cytochromes P-450 in the biosynthesis of steroid hormones, Vitam. Horm. 42 (1985) 315-368.
10. S. Lieberman, Y.Y. Lin, Reflections on sterol sidechain cleavage process catalyzed by cytochrome P450(scc), J. Steroid Biochem. Mol. Biol. 78 (2001) 1-14.
11. T. Tajima, K. Fujieda, N. Kouda, J. Nakae, W.L. Miller, Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency, J. Clin. Endocrinol. Metab. 86 (2001) 3820-3825.
12. R.C. Brown, V. Papadopoulos, Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis, Int. Rev. Neurobiol. 46 (2001) 117-143.
13. D.M. Stocco, Clinical disorders associated with abnormal cholesterol transport: mutations in the steroidogenic acute regulatory protein, Mol. Cell. Endocrinol. 191 (2002) 19-25.
14. M.R. Waterman, Steroidogenesis, StAR and PBR: is there light at the end of the tunnel?, Proc. Soc. Exp. Biol. Med. 217 (1998) 121-122.
15. W.L. Miller, J.F. Strauss, Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR, J. Steroid Biochem. Mol. Biol. 69 (1999) 131-141.
16. V. Papadopoulos, Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function, Endocr. Rev. 14 (1993) 222-240.
17. V. Luu-The, M. Takahashi, Y. de Launoit, M. Dumont, Y. Lachance, F. Labrie, Evidence for distinct dehydrogenase and isomerase sites within a single 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase protein, Biochemistry 30 (1991) 8861-8865.
18. T.M. Penning, Molecular endocrinology of hydroxysteroid dehydrogenases, Endocr. Rev. 18 (1997) 281-305.
19. Y. Lachance, V. Luu-The, C. Labrie, J. Simard, M. Dumont, Y. de Launoit, S. Guerin, G. Leblanc, F. Labrie, Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells, J. Biol. Chem. 265 (1990) 20469-20475.
20. Y. Lachance, V. Luu-The, H. Verreault, M. Dumont, E. Rheaume, G. Leblanc, F. Labrie, Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity, DNA Cell Biol. 10 (1991) 701-711.
21. J. Simard, E. Rheaume, F. Mebarki, R. Sanchez, M.I. New, Y. Morel, F. Labrie, Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency, J. Steroid Biochem. Mol. Biol. 53 (1995) 127-138.
22. H.K. Lin, C.F. Hung, M. Moore, T.M. Penning, Genomic structure of rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD, AKR1C9), J. Steroid Biochem. Mol. Biol. 71 (1999) 29-39.
23. J.J. Lambert, S.C. Harney, D. Belelli, J.A. Peters, Neurosteroid modulation of recombinant and synaptic GABAA receptors, Int. Rev. Neurobiol. 46 (2001) 177-205.
24. S.M. Paul, R.H. Purdy, Neuroactive steroids, FASEB J. 6 (1992) 2311-2322.
25. R. Rupprecht, J.M. Reul, T. Trapp, S. Van, C. Wetzel, K. Damm, W. Ziegelgänsberger, F. Holsboer, Progesterone receptor-mediated effects of neuroactive steroids, Neuron 11 (1993) 523-530.
26. A.I. Csapo, M. Pulkkinen, Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence, Obstet. Gynecol. Surv. 33 (1978) 69-81.
27. J.P. Gutai, W.J. Meyer, A.A. Kowarski, C.J. Migeon, Twenty-four hour integrated concentrations of progesterone, 17-hydroxyprogesterone and cortisol in normal male subjects, J. Clin. Endocrinol. Metab. 44 (1977) 116-120.
28. P. Robel, M. Schumacher, E.E. Baulieu, Neurosteroids: from definition and biochemistry to physiopathologic function, in: E.E. Baulieu, P. Robel, M. Schumacher (Eds.), Neurosteroids. A New Regulatory Function in the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 1-25.
29. K. Tsutsui, K. Ukena, M. Usui, H. Sakamoto, M. Takase, Novel brain function: biosynthesis and actions of neurosteroids in neurons, Neurosci. Res. 36 (2000) 261-273.
30. S.H. Mellon, L.D. Griffin, N.A. Compagnone, Biosynthesis and action of neurosteroids, Brain Res. Rev. 37 (2001) 3-12.
31. S.H. Mellon, H. Vaudry, Biosynthesis of neurosteroids and regulation of their synthesis, Int. Rev. Neurobiol. 46 (2001) 33-78.
32. V. Papadopoulos, P. Guarneri, K.E. Krueger, A. Guidotti, E. Costa, Pregnenolone biosynthesis in C6-2B glioma cell mitochondria - regulation by a mitochondrial diazepam binding inhibitor receptor, Proc. Natl. Acad. Sci. USA 89 (1992) 5113-5117.
33. D. Bitran, M. Foley, D. Audette, N. Leslie, C.A. Frye, Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat, Psychopharmacology (Berlin) 151 (2000) 64-71.
34. A. Korneyev, B.S. Pan, A. Polo, E. Romeo, A. Guidotti, E. Costa, Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo, J. Neurochem. 61 (1993) 1515-1524.
35. M. Serra, P. Madau, M.F. Chessa, M. Caddeo, E. Sanna, G. Trapani, M. Franco, G. Liso, R.H. Purdy, M. Barbaccia, G. Biggio, 2-Phenyl-imidazo[1,2-α]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats, Br. J. Pharmacol. 127 (1999) 177-187.
36. N. Miyazawa, M. Diksic, Y. Yamamoto, Chronological study of peripheral benzodiazepine binding sites in the rat brain stab wounds using [3H] PK-11195 as a marker for gliosis, Acta Neurochir. (Wien.) 137 (1995) 207-216.
37. A.C. Kuhlmann, T.R. Guilarte, The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity, Brain Res. 751 (1997) 281-288.
38. D.R. Gehlert, D.T. Stephenson, D.A. Schober, K. Rash, J.A. Clemens, Increased expression of peripheral benzodiazepine receptors in the facial nucleus following motor neuron axotomy, Neurochem. Int. 31 (1997) 705-713.
39. D. Bitran, D. Carlson, S. Leschiner, M. Gavish, Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density, Eur. J. Pharmacol. 361 (1998) 235-242.
40. C. Le Goascogne, B. Eychenne, M.C. Tonon, F. Lachapelle, N. Baumann, P. Robel, Neurosteroid progesterone is up-regulated in the brain of Jimpy and Shiverer mice, Glia 29 (2000) 14-24.
41. P. Lacor, P. Gandolfo, M.C. Tonon, E. Brault, I. Dalibert, M. Schumacher, J. Benavides, B. Ferzaz, Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis, Brain Res. 815 (1999) 70-80.
42. A. Furukawa, A. Miyatake, T. Ohnishi, Y. Ichikawa, Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450SCC (CYP XIA1), and 3beta-hydroxysteroid dehydrogenase in the rat brain, J. Neurochem. 71 (1998) 2231-2238.
43. S.R. King, P.R. Manna, T. Ishii, P.J. Syapin, S.D. Ginsberg, K. Wilson, L.P. Walsh, K.L. Parker, D.M. Stocco, R.G. Smith, D.J. Lamb, An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain, J. Neurosci. 22 (2002) 10613-10620.
44. R. Guennoun, R.J. Fiddes, M. Gouézou, M. Lombès, E.E. Baulieu, A key enzyme in the biosynthesis of neurosteroids, 3β-hydroxysteroid dehydrogenase/Delta5-Delta4-isomerase (3β -HSD), is expressed in rat brain, Mol. Brain Res. 30 (1995) 287-300.
45. K. Ukena, C. Kohchi, K. Tsutsui, Expression and activity of 3beta-hydroxysteroid dehydrogenase/delta5-delta4-isomerase in the rat Purkinje neuron during neonatal life, Endocrinology 140 (1999) 805-813.
46. C. Kohchi, K. Ukena, K. Tsutsui, Age- and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes P450scc, P450c17 and 3beta-HSD in the postnatal rat brain, Brain Res. 801 (1998) 233-238.
47. C. Ibanez, R. Guennoun, P. Liere, B. Eychenne, A. Pianos, M. El-Etr, E.E. Baulieu, M. Schumacher, Developmental expression of genes involved in neurosteroidogenesis: 3β-hydroxysteroid-dehydrogenase/Δ5-Δ4 isomerase in the rat brain, Endocrinology 144 (2003) 2902-2911.
48. A.G. Mensah-Nyagan, M. Feuilloley, E. Dupont, J.L. Do-Rego, F. Leboulenger, G. Pelletier, H. Vaudry, Immunocytochemical localization and biological activity of 3β-hydroxysteroid dehydrogenase in the central nervous system of the frog, J. Neurosci. 14 (1994) 7306-7318.
49. Z.Y. Hu, I. Jung-Testas, P. Robel, E.E. Baulieu, Neurosteroids: steroidogenesis in primary cultures of rat glial cells after release of aminoglutethimide blockade, Biochem. Biophys. Res. Commun. 161 (1989) 917-922.
50. I. Jung-Testas, Z.Y. Hu, P. Robel, E.E. Baulieu, Biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells, Endocrinology 125 (1989) 2083-2091.
51. K. Kabbadj, M. El Etr, E.E. Baulieu, P. Robel, Pregnenolone metabolism in rodent embryonic neurons and astrocytes, Glia 7 (1993) 170-175.
52. Y. Akwa, N.G. Sananès, P. Robel, E.E. Baulieu, C. Le Goascogne, Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density, J. Cell Biol. 121 (1993) 135-143.
53. I.H. Zwain, S.S. Yen, Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain, Endocrinology 140 (1999) 3843-3852.
54. N. Gago, Y. Akwa, N. Sananes, R. Guennoun, E.E. Baulieu, M. El Etr, M. Schumacher, Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism, Glia 36 (2001) 295-308.
55. J.R. Chan, L.J. Phillips, M. Glaser, Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation, Proc. Natl. Acad. Sci. USA 95 (1998) 10459-10464.
56. H. Coirini, M. Gouezou, P. Liere, B. Delespierre, A. Pianos, B. Eychenne, M. Schumacher, R. Guennoun, 3-beta-hydroxysteroid dehydrogenase expression in rat spinal cord, Neuroscience 113 (2002) 883-891.
57. J.L. Sanne, K.E. Krueger, Expression of cytochrome P450 side-chain cleavage enzyme and 3β-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization, J. Neurochem. 65 (1995) 528-536.
58. R. Guennoun, M. Schumacher, F. Robert, B. Delespierre, M. Gouézou, B. Eychenne, Y. Akwa, P. Robel, E.E. Baulieu, Neurosteroids: expression of functional 3β-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells, Eur. J. Neurosci. 9 (1997) 2236-2247.
59. F. Robert, R. Guennoun, F. Désarnaud, A. Do-Thi, Y. Benmessahel, E.E. Baulieu, M. Schumacher, Synthesis of progesterone in Schwann cells: regulation by sensory neurons, Eur. J. Neurosci. 13 (2001) 916-924.
60. H. Coirini, M. Gouezou, B. Delespierre, P. Liere, A. Pianos, B. Eychenne, M. Schumacher, R. Guennoun, Characterization and regulation of the 3beta-hydroxysteroid dehydrogenase isomerase enzyme in the rat sciatic nerve, J. Neurochem. 84 (2003) 119-126.
61. A. Lanthier, V.V. Patwardhan, Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves, J. Steroid Biochem. 25 (1986) 445-449.
62. C. Lacroix, J. Fiet, J.P. Benais, B. Gueux, R. Bonete, J.M. Villette, B. Gourmel, C. Dreux, Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain, J. Steroid Biochem. 28 (1987) 317-325.
63. M. Bixo, A. Andersson, B. Winblad, R.H. Purdy, T. Bäckström, Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states, Brain Res. 764 (1997) 173-178.
64. S. Weill-Engerer, J.P. David, V. Sazdovitch, P. Liere, B. Eychenne, A. Pianos, M. Schumacher, A. Delacourte, E.E. Baulieu, Y. Akwa, Neurosteroid quantification in human brain regions: comparison between Alzheimer's and non-demented patients, J. Clin. Endocrinol. Metab. 87 (2002) 5138-5143.
65. R. Morfin, J. Young, C. Corpéchot, B. Egestad, J. Sjövall, E.E. Baulieu, Neurosteroids: pregnenolone in human sciatic nerves, Proc. Natl. Acad. Sci. USA 89 (1992) 6790-6793.
66. C. Le Goascogne, M. Gouézou, P. Robel, G. Defaye, E. Chambaz, M.R. Waterman, E.E. Baulieu, The cholesterol side-chain cleavage complex in human brain white matter, J. Neuroendocrinol. 1 (1989) 153-156.
67. S. Beyenburg, B. Stoffel-Wagner, M. Watzka, I. Blumcke, J. Bauer, J. Schramm, F. Bidlingmaier, C.E. Elger, Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy, Neuroreport 10 (1999) 3067-3070.
68. M. Watzka, F. Bidlingmaier, J. Schramm, D. Klingmuller, B. Stoffel-Wagner, Sex- and age-specific differences in human brain CYP11A1 mRNA expression, J. Neuroendocrinol. 11 (1999) 901-905.
69. T. Inoue, J. Akahira, T. Suzuki, A.D. Darnel, C. Kaneko, K. Takahashi, M. Hatori, R. Shirane, T. Kumabe, Y. Kurokawa, S. Satomi, H. Sasano, Progesterone production and actions in the human central nervous system and neurogenic tumors, J. Clin. Endocrinol. Metab. 87 (2002) 5325-5331.
70. L. Yu, D.G. Romero, C.E. Gomez-Sanchez, E.P. Gomez-Sanchez, Steroidogenic enzyme gene expression in the human brain, Mol. Cell. Endocrinol. 190 (2002) 9-17.
71. R.C. Brown, C. Cascio, V. Papadopoulos, Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide, J. Neurochem. 74 (2000) 847-859.
72. N.J. MacLusky, B.S. McEwen, Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites, Endocrinology 106 (1980) 192-202.
73. K. Hagihara, S. Hirata, T. Osada, M. Hirai, J. Kato, Distribution of cells containing progesterone receptor mRNA in the female rat di- and telencephalon: an in situ hybridization study, Brain Res. 14 (1992) 239-249.
74. J. Kato, S. Hirata, A. Nozawa, N. Yamada-Mouri, Gene expression of progesterone receptor isoforms in the rat brain, Horm. Behav. 28 (1994) 454-463.
75. B. Parsons, T.C. Rainbow, N.J. MacLusky, B.S. McEwen, Progestin receptor levels in rat hypothalamic and limbic nuclei, J. Neurosci. 2 (1982) 1446-1452.
76. N.J. MacLusky, B.S. McEwen, Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others, Nature 274 (1978) 276-277.
77. I. Camacho-Arroyo, G. Perez-Palacios, A.M. Pasapera, M.A. Cerbon, Intracellular progesterone receptors are differentially regulated by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit, J. Steroid Biochem. Mol. Biol. 50 (1994) 299-303.
78. F. Labombarda, R. Guennoun, S. Gonzalez, P. Roig, A. Lima, M. Schumacher, A.F. De Nicola, Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord, Neurosci. Lett. 288 (2000) 29-32.
79. I. Jung-Testas, M. Schumacher, P. Robel, E.E. Baulieu, Demonstration of progesterone receptors in rat Schwann cells, J. Steroid Biochem. Mol. Biol. 58 (1996) 77-82.
80. I. Jung-Testas, J.M. Renoir, J.M. Gasc, E.E. Baulieu, Estrogen-inducible progesterone receptor in primary cultures of rat glial cells, Exp. Cell Res. 193 (1991) 12-19.
81. A.N. Do Thi, I. Jung-Testas, E.E. Baulieu, Neuronal signals are required for estrogen-mediated induction of progesterone receptor in cultured rat Schwann cells, J. Steroid Biochem. Mol. Biol. 67 (1998) 201-211.
82. J.D. Blaustein, M.N. Lehman, J.C. Turcotte, G. Greene, Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus, Endocrinology 131 (1992) 281-290.
83. J.D. Blaustein, Estrogen receptors in neurons: new subcellular locations and functional implications, Endocrine J. 2 (1994) 249-258.
84. Z. Chen, I.S. Yuhanna, Z. Galcheva-Gargova, R.H. Karas, M.E. Mendelsohn, P.W. Shaul, Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen, J. Clin. Invest. 103 (1999) 401-406.
85. V. Boonyaratanakornkit, M.P. Scott, V. Ribon, L. Sherman, S.M. Anderson, J.L. Matter, W.T. Miller, D.P. Edwards, Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases, Mol. Cell 8 (2001) 269-280.
86. C. Beyer, T. Ivanova, M. Karolczak, E. Kuppers, Cell type-specificity of nonclassical estrogen signaling in the developing midbrain, J. Steroid Biochem. Mol. Biol. 81 (2002) 319.
87. M.D. Majewska, N.L. Harrison, R.D. Schwartz, J.L. Barker, S.M. Paul, Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor, Science 232 (1986) 1004-1007.
88. T.P. Su, E.D. London, J.H. Jaffe, Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems, Science 240 (1988) 219-221.
89. S. Bastianetto, F. Monnet, J.L. Junien, R. Quirion, Steroidal modulation of sigma receptor function, in: E.E. Baulieu, P. Robel, M. Schumacher (Eds.), Neurosteroids. A New Regulatory Function in the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 191-205.
90. B. Buisson, D. Bertrand, Steroid modulation of the nicotinic acetylcholine receptor, in: E.E. Baulieu, P. Robel, M. Schumacher (Eds.), Neurosteroids. A New Regulatory Function in the Nervous System, 207, Humana Press, Totowa, NJ, 1999, pp. 207-223.
91. S.A. Tischkau, V.D. Ramirez, A specific membrane binding protein for progesterone in rat brain: sex differences and induction by estrogen, Proc. Natl. Acad. Sci. USA 90 (1993) 1285-1289.
92. C.J. Krebs, E.D. Jarvis, J. Chan, J.P. Lydon, S. Ogawa, D.W. Pfaff, A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behavior, Proc. Natl. Acad. Sci. USA 97 (2000) 12816-12821.
93. M. Schumacher, F. Robert, Progesterone: synthesis, metabolism, mechanisms of action, and effects in the nervous system, in: D.W. Pfaff, A.P. Arnold, A.M. Etgen, S.E. Fahrbach, R.T. Rubin (Eds.), Hormones, Brain and Behavior, vol. 3, Academic Press, Amsterdam, 2002, pp. 683-745.
94. E. Falkenstein, C. Eisen, K. Schmieding, M. Krautkramer, C. Stein, R. Losel, M. Wehling, Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes, Mol. Cell. Biochem. 218 (2001) 71-79.
95. Y. Zhu, P. Thomas, Identification, classification and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor, Proc. Natl. Acad. Sci. USA 100 (2003) 2237-2242.
96. M.J. Attella, A. Nattinville, D.G. Stein, Hormonal state affects recovery from frontal cortex lesions in adult female rats, Behav. Neural. Biol. 48 (1987) 352-367.
97. D.G. Stein, Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?, Trends Neurosci. 24 (2001) 386-391.
98. R.L. Roof, R. Duvdevani, D.G. Stein, Gender influences outcome of brain injury: progesterone plays a protective role, Brain Res. 607 (1993) 333-336.
99. R.L. Roof, R. Duvdevani, J.W. Heyburn, D.G. Stein, Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective, Exp. Neurol. 138 (1996) 246-251.
100. R.L. Roof, R. Duvdevani, L. Braswell, D.G. Stein, Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats, Exp. Neurol. 129 (1994) 64-69.
101. W.H. Yu, Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment, Brain Res. 491 (1989) 379-382.
102. N. Jiang, M. Chopp, D. Stein, H. Feit, Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats, Brain Res. 735 (1996) 101-107.
103. A.J. Thomas, R.P. Nockels, H.Q. Pan, C.I. Shaffrey, M. Chopp, Progesterone is neuroprotective after acute experimental spinal cord trauma in rats, Spine 24 (1999) 2134-2138.
104. L. Guth, Z. Zhang, E. Roberts, Key role for pregnenolone in combination therapy promotes recovery after spinal cord injury, Proc. Natl. Acad. Sci. USA 91 (1994) 12308-12312.
105. K. Murakami, A. Fellous, E.E. Baulieu, P. Robel, Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly, Proc. Natl. Acad. Sci. USA 97 (2000) 3579-3584.
106. M.C. Gonzalez Deniselle, J.J. Lopez-Costa, J.P. Saavedra, L. Pietranera, S.L. Gonzalez, L. Garay, R. Guennoun, M. Schumacher, A.F. De Nicola, Progesterone neuroprotection in the wobbler mouse, a genetic model of spinal cord motor neuron disease, Neurobiol. Dis. 11 (2002) 457-468.
107. L.W. Duchen, S.J. Strich, An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobble', J. Neurol. Neurosurg. Psychiatry 31 (1968) 535-542.
108. D.L. Price, D.W. Cleveland, V.E. Koliatsos, Motor neurone disease and animal models, Neurobiol. Dis. 1 (1994) 3-11.
109. M.C. Gonzalez Deniselle, J.J. Lopez Costa, S.L. Gonzalez, F. Labombarda, L. Garay, R. Guennoun, M. Schumacher, A.F. De Nicola, Basis of progesterone protection in spinal cord neurodegeneration, J. Steroid. Biochem. Mol. Biol. 83 (2002) 199-209.
110. R.L. Roof, S.W. Hoffman, D.G. Stein, Progesterone protects against lipid peroxidation following traumatic brain injury in rats, Mol. Chem. Neuropathol. 31 (1997) 1-11.
111. R.L. Roof, E.D. Hall, Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone, J. Neurotrauma 17 (2000) 367-388.
112. S.S. Smith, Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells, Neuroscience 42 (1991) 309-320.
113. T. Ogata, Y. Nakamura, K. Tsuji, T. Shibata, K. Kataoka, Steroid hormones protect spinal cord neurons from glutamate toxicity, Neuroscience 55 (1993) 445-449.
114. A.F. De Nicola, F. Labombarda, S.L. Gonzalez, M.C. Gonzalez Deniselle, R. Guennoun, M. Schumacher, Steroid effects on glial cells: detrimental or protective for spinal cord injury?, Ann. N.Y. Acad. Sci. 1007 (2003) 317-328.
115. F. Labombarda, S. Gonzalez, P. Roig, A. Lima, R. Guennoun, M. Schumacher, A.F. De Nicola, Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured rat spinal cord, J. Steroid Biochem. Mol. Biol. 73 (2000) 159-169.
116. D.W. Choi, Nitric oxide: foe or friend to the injured brain?, Proc. Natl. Acad. Sci. USA 90 (1993) 9741-9743.
117. F. Labombarda, S.L. Gonzalez, D.M. Gonzalez, R. Guennoun, M. Schumacher, A.F. De Nicola, Cellular basis for progesterone neuroprotection in the injured spinal cord, J. Neurotrauma 19 (2002) 343-355.
118. F. di Michele, D. Lekieffre, A. Pasini, G. Bernardi, J. Benavides, E. Romeo, Increased neurosteroids synthesis after brain and spinal cord injury in rats, Neurosci. Lett. 284 (2000) 65-68.
119. H. Sakamoto, K. Ukena, K. Tsutsui, Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis, J. Neurosci. 21 (2001) 6221-6232.
120. H. Sakamoto, H. Shikimi, K. Ukena, K. Tsutsui, Neonatal expression of progesterone receptor isoforms in the cerebellar Purkinje cell in rats, Neurosci. Lett. 343 (2003) 163-166.
121. H. Sakamoto, K. Ukena, K. Tsutsui, Dendritic spine formation in response to progesterone synthesized de novo in the developing Purkinje cell in rats, Neurosci. Lett. 322 (2002) 111-115.
122. M. Schumacher, R. Guennoun, G. Mercier, F. Desarnaud, P. Lacor, J. Benavides, B. Ferzaz, F. Robert, E.E. Baulieu, Progesterone synthesis and myelin formation in peripheral nerves, Brain Res. Rev. 37 (2001) 343-359.
123. H. Koenig, M. Schumacher, B. Ferzaz, A.N. Do Thi, A. Ressouches, R. Guennoun, I. Yung-Testas, P. Robel, Y. Akwa, E.E. Baulieu, Progesterone synthesis and myelin formation by Schwann cells, Science 268 (1995) 1500-1503.
124. R.C. Melcangi, V. Magnaghi, L. Martini, Steroid metabolism and effects in central and peripheral glial cells, J. Neurobiol. 40 (1999) 471-483.
125. V. Magnaghi, I. Cavarretta, M. Galbiati, L. Martini, R.C. Melcangi, Neuroactive steroids and peripheral myelin proteins, Brain Res. Rev. 37 (2001) 360-371.
126. J.R. Chan, P.M. Rodriguez-Waitkus, B.K. Ng, P. Liang, M. Glaser, Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression, Mol. Biol. Cell 11 (2000) 2283-2295.
127. G. Lemke, The molecular genetics of myelination: an update, Glia 7 (1993) 263-271.
128. A. Messing, R.R. Behringer, J.P. Hammang, R.D. Palmiter, R.L. Brinster, G. Lemke, Po promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice, Neuron 8 (1992) 507-520.
129. P. Topilko, S. Schneider-Maunoury, G. Levi, A. Baron-Van Evercooren, A.B.Y. Chennoufi, T. Seitanidou, C. Babinet, P. Charnay, Krox-20 controls myelination in the peripheral nervous system, Nature 371 (1994) 796-799.
130. C. Goujet-Zalc, C. Babinet, M. Monge, S. Timsit, F. Cabon, A. Gansmuller, M. Miura, M. Sanchez, S. Pournin, K. Mikoshiba, B. Zalc, The proximal region of the MBP gene promoter is sufficient to induce oligodendroglial-specific expression in transgenic mice, Eur. J. Neurosci. 5 (1993) 624-632.
131. A.M. Ghoumari, C. Ibanez, M. El-Etr, P. Leclerc, B. Eychenne, E.E. Baulieu, M. Schumacher, Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum, J. Neurochem. 86 (2003) 848-859.
132. A. Peters, Structural changes in the normally aging cerebral cortex of primates, Prog. Brain Res. 136 (2002) 455-465.
133. J.H. Sandell, A. Peters, Effects of age on nerve fibers in the rhesus monkey optic nerve, J. Comp. Neurol. 429 (2001) 541-553.
134. R.C. Melcangi, V. Magnaghi, I. Cavarretta, M.A. Riva, F. Piva, L. Martini, Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging, Exp. Gerontol. 33 (1998) 827-836.
135. R.C. Melcangi, V. Magnaghi, I. Cavarretta, L. Martini, F. Piva, Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives, Neuroscience 85 (1998) 569-578.
136. I. Azcoitia, E. Leonelli, V. Magnaghi, S. Veiga, L.M. Garcia-Segura, R.C. Melcangi, Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats, Neurobiol. Aging 24 (2003) 853-860.
137. J. Gilson, W.F. Blakemore, Failure of remyelination in areas of demyelination produced in the spinal cord of old rats, Neuropathol. Appl. Neurobiol. 19 (1993) 173-181.
138. S.A. Shields, J.M. Gilson, W.F. Blakemore, R.J. Franklin, Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination, Glia 28 (1999) 77-83.
139. C. Ibanez, S.A. Shields, P. Liere, M. El-Etr, E.E. Baulieu, M. Schumacher, R.J.M. Franklin, Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats, Neuropathol. Appl. Neurobiol. 30 (2003) 80-89.
140. F.J. Sim, C. Zhao, J. Penderis, R.J.M. Franklin, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci. 22 (2002) 2451-2459.
141. G.L. Hinks, R.J.M. Franklin, Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats, Mol. Cell. Neurosci. 16 (2000) 542-556.
142. S.J. Jones, Visual evoked potentials after optic neuritis, J. Neurol. 240 (1993) 489-494.
143. B.S. McEwen, S.E. Alves, Estrogen actions in the central nervous system, Endocr. Rev. 20 (1999) 279-307.
144. L.M. Garcia-Segura, I. Azcoitia, L.L. Doncarlos, Neuroprotection by estradiol, Prog. Neurobiol. 63 (2001) 29-60.
145. S.J. Lee, B.S. McEwen, Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications, Annu. Rev. Pharmacol. Toxicol. 41 (2001) 569-591.
146. P.M. Wise, D.B. Dubal, M.E. Wilson, S.W. Rau, M. Bottner, K.L. Rosewell, Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies, Brain Res. Rev. 37 (2001) 313-319.
147. M. Barham, Selective estrogen-receptor modulators, N. Engl. J. Med. 348 (2003) 2259.
148. K. Chwalisz, R. Garg, R.M. Brenner, G. Schubert, W. Elger, Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis, Ann. N. Y. Acad. Sci. 955 (2002) 373-388.
149. K.M. Dhandapani, D.W. Brann, Protective effects of estrogen and selective estrogen receptor modulators in the brain, Biol. Reprod. 67 (2002) 1379-1385.
150. V. Krishnan, H. Heath, H.U. Bryant, Mechanism of action of estrogens and selective estrogen receptor modulators, Vitam. Horm. 60 (2000) 123-147.
151. K. Littleton, N.L. Ostrowski, D.A. Cox, M.I. Rossberg, P.D. Hurn, Selective estrogen receptor modulators: tissue actions and potential for CNS protection, CNS Drug Rev. 8 (2002) 309-330.
152. M.D. Whitaker, Selective estrogen receptor modulators: from bench to bedside and back, Endocr. Pract. 7 (2001) 113-119.
153. K. Yaffe, Estrogens, selective estrogen receptor modulators, and dementia: what is the evidence?, Ann N. Y. Acad. Sci. 949 (2001) 215-222.
154. D.F. Covey, M. Han, A.S. Kumar, C. de La, E.S. Meadows, Y. Hu, A. Tonnies, D. Nathan, M. Coleman, A. Benz, A.S. Evers, C.F. Zorumski, S. Mennerick, Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha, 5beta)-3-hydroxypregnan-20-one, J. Med. Chem. 43 (2000) 3201-3204.
155. Y. Akwa, N. Ladurelle, D.F. Covey, E.E. Baulieu, The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?, Proc. Natl. Acad. Sci. USA 98 (2001) 14033-14037.
156. G.P. Cardona-Gomez, P. Mendez, L.M. Garcia-Segura, Synergistic actions of estradiol and insulin-like growth factor-I in the activation of P13K/Akt signaling in the adult hypothalamus, Mol. Brain Res. 107 (2002) 80-88.
157. G. Cardona, J.A. Chowen, S. Garcia, Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats, J. Neurobiol. 43 (2000) 269-281.
158. E.L. Gregoraszczuk, T. Milewicz, J. Kolodziejczyk, J. Krzysiek, A. Basta, K. Sztefko, S. Kurek, J. Stachura, Progesterone-induced secretion of growth hormone, insulin-like growth factor I and prolactin by human breast cancer explants, Gynecol. Endocrinol. 15 (2001) 251-258.
159. X. Cui, P. Zhang, W. Deng, S. Oesterreich, Y. Lu, G.B. Mills, A.V. Lee, Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer, Mol. Endocrinol. 17 (2003) 575-588.
160. E. Romeo, S. Cavallaro, A. Korneyev, A.P. Kozikowski, D. Ma, A. Polo, E. Costa, A. Guidotti, Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex, J. Pharmacol. Exp. Ther. 267 (1993) 462-471.
161. P. Guarneri, V. Papadopoulos, B.S. Pan, E. Costa, Regulation of pregnenolone synthesis in C6-2B glioma cells by 4′ -chlorodiazepam, Proc. Natl. Acad. Sci. USA 89 (1992) 5118-5122.
162. G. Trapani, M. Franco, A. Latrofa, L. Ricciardi, A. Carotti, M. Serra, E. Sanna, G. Biggio, G. Liso, Novel 2-phenylimidazo-[1,2-a]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity, and in vivo studies, J. Med. Chem. 42 (1999) 3934-3941.
163. Women's Health Initiative Investigators, Effect of estrogen plus progestin on stroke in postmenopausal women, JAMA 289 (2003) 2673-2684.
164. Women's Health Initiative Investigators, Effect of estrogen plus progestin on global cognitive function in postmenopausal women, JAMA 289 (2003) 2663-2672.
165. Women's Health Initiative Investigators, Effect of estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women, JAMA 289 (2003) 2651-2662.
166. Women's Health Initiative Investigators, Effects of estrogen plus progestin on health-related quality of life, N. Engl. J. Med. 348 (2003) 1839-1854.
167. Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, JAMA 288 (2002) 321-333.